Dual-color tumor-host imaging models
Dual-color tumor-host imaging models
批准号:
7234290
负责人:
MENG YANG
金额:
$37.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2008-04-30
关键词:
Amino Acid SequenceAnesthesia proceduresAnimalsBlood VesselsBreastCellsCodeColonColorCompatibleComplexDarknessDetectionDevelopmentDisease regressionDrug Delivery SystemsElementsEnvironmentErythrocytesFirefly LuciferasesFluorescenceGenus ColaGreen Fluorescent ProteinsHairHumanImageImplantInjection of therapeutic agentLabelLentivirus VectorLifeLightLuciferasesMalignant NeoplasmsMalignant neoplasm of prostateMammalian CellModelingMusNeoplasm MetastasisNude MiceOpticsOrganPeptide Sequence DeterminationPharmaceutical PreparationsPhasePhotonsProcessProliferatingProteinsRenilla LuciferasesReporterReporter GenesResolutionSignal TransductionSimplexvirusSkinSolid NeoplasmStromal CellsStromal NeoplasmSurgical FlapsTechniquesTestingTherapeutic AgentsThymidine KinaseTimeTissuesTransplantationTumor AngiogenesisVascular blood supplyYangangiogenesisantiangiogenesis therapyanticancer researchbeta Actincell typecellular imagingcharge coupled device cameracostdrug discoveryfluorescence imaginghigh throughput screeninghost neoplasm interactionhuman cancer mouse modelin vivoinstrumentationinterestluciferinmouse modelmutantneoplastic cellnestin proteinpromoterred fluorescent proteinresponserestrainttherapeutic angiogenesisthree dimensional structuretumortumor growthvector
中文摘要
描述(申请人提供):这项第二阶段申请将进一步开发在第一阶段申请中开发的双色可成像的肿瘤-宿主-相互作用裸鼠模型,用于第三阶段,以发现和评估用于间质治疗的新的有效药物,包括血管生成。宿主模型是在β-肌动蛋白启动子(Bad-GFP)控制下普遍表达绿色荧光蛋白(GFP)的裸鼠(Yang,M.,等,Proc.娜塔莉。阿卡德。SCI。美国98,2616-2621,2001和杨明,等,癌症研究,,8651-8656,2004)和巢蛋白驱动的绿色荧光蛋白(ND-GFP)裸鼠,其中新生血管被绿色荧光蛋白标记(Amoh,Y.等人,癌症研究65,5352-5357,2005)。除红细胞和毛发外,BAD-GFP小鼠的所有组织在蓝色激发光下都发出绿色荧光。在ND-GFP小鼠中,新生血管表达GFP。在BAD-GFP模型中,移植的表达红色荧光蛋白(RFP)的肿瘤和表达GFP的基质细胞可以同时清晰地显示出来。将在BAD-GFP和ND-GFP模型中开发人乳腺癌、结肠癌和前列腺癌的双色原位模型,以成像原发和转移性肿瘤与宿主的相互作用。双色成像使肿瘤和宿主组织的分辨率下降到单细胞水平。所有与肿瘤相互作用的宿主基质细胞都可以在Bad-GFP模型中唯一地成像,包括活鼠。基质细胞是新的基质疗法的靶点。新生的肿瘤血管生成可以在ND-GFP模型中唯一地被成像。新生血管生成是抗肿瘤和抗转移治疗的潜在关键靶点,在活体ND-GFP裸鼠体内的人类肿瘤中是唯一可见的。这些人类癌症的彩色编码裸鼠模型将被用于可视化新的靶点,这将极大地促进基质靶向和抗血管生成药物的发现。其具体目标包括:(1)利用Bad-GFP裸鼠和表达RFP的人肿瘤建立双色肿瘤-宿主模型,以寻找基质靶向的治疗药物。(2)建立含RFP原位表达肿瘤模型的ND-GFP裸鼠双色肿瘤-宿主模型,以寻找针对新生血管生成的特异性靶点。这些模型在发现和开发基质靶向和抗血管生成药物方面具有巨大的商业潜力。
英文摘要
DESCRIPTION (provided by applicant): This Phase II application will further develop dual-color imageable tumor-host-interaction nude mouse models, developed in the Phase I application, to be used in Phase III to discover and evaluate new effective agents for stromal therapy, including angiogenesis. The host models are the ubiquitously-expressing green fluorescent protein (GFP)-nude mouse with GFP under control of the beta-actin promoter (BAD-GFP) (Yang, M., et al., Proc. Natl. Acad. Sci. USA 98, 2616-2621, 2001 and Yang, M., et al., Cancer Research, 64, 8651- 8656, 2004) and the nestin-driven-GFP (ND-GFP) nude mouse in which nascent blood vessels are labeled with GFP (Amoh, Y., et al., Cancer Res. 65, 5352-5357, 2005). All of the tissues of the BAD-GFP mice, with the exception of erythrocytes and hair, fluoresce green under blue excitation light. In ND-GFP mice, nascent blood vessels express GFP. Transplanted red fluorescent protein (RFP)-expressing tumors and GFP- expressing stromal cells can be clearly imaged simultaneously in the BAD-GFP models. Dual-color orthotopic models of human breast, colon and prostate cancer will be developed in both the BAD-GFP and ND-GFP models to image tumor-host interaction in both primary and resulting metastases. Dual-color imaging enables resolution of the tumor and the host tissues down to the single cell level. All tumor- interacting host stromal cells can be uniquely imaged in the BAD-GFP model including live mice. The stromal cells are targets for new stromal therapy. Nascent tumor angiogenesis can be uniquely imaged in the ND- GFP model. Nascent angiogenesis is a potentially critical target for antitumor and antimetastatic therapy and is uniquely visualized in human tumors in the live ND-GFP nude mouse. These color-coded nude mouse models of human cancer will be used to visualize new targets which should greatly enhance the discovery of stromal-targeting and anti-angiogenesis drugs. The specific aims include: (1) Development of dual-color tumor-host models with the BAD-GFP nude mouse with orthotopic RFP-expressing human tumors for discovery of stroma-targeted therapeutic agents. (2) Development of dual-color tumor-host models with the ND-GFP nude mouse with orthotopic RFP-expressing tumor models for discovery of specific agents which target nascent angiogenesis. These models have significant commercial potential for discovery and development of stroma-targeted and anti-angiogenesis drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pancreatic-Cancer Imageable Patient-Derived Orthotopic Xenografts (iPDOX)
-
批准号:8780448
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2014
-
负责人:MENG YANG
-
依托单位:
Therapeutic hair follicle-derived neurospheres
-
批准号:6934274
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2005
-
负责人:MENG YANG
-
依托单位:
Orthotopic models of tumor angiogenesis and blood flow
-
批准号:7160990
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2003
-
负责人:MENG YANG
-
依托单位:
Orthotopic models of tumor angiogenesis and blood flow
-
批准号:7292746
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2003
-
负责人:MENG YANG
-
依托单位:
Therapeutic hair follicle-derived neurospheres
-
批准号:7275359
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2003
-
负责人:MENG YANG
-
依托单位:
Dual-color tumor-host imaging models
-
批准号:7109037
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2003
-
负责人:MENG YANG
-
依托单位:
Therapeutic hair follicle-derived neurospheres
-
批准号:7159296
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2003
-
负责人:MENG YANG
-
依托单位:
Orthotopic models of tumor angiogenesis and blood flow
-
批准号:6582762
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2003
-
负责人:MENG YANG
-
依托单位:
Dual-color tumor-host imaging models
-
批准号:6694637
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2003
-
负责人:MENG YANG
-
依托单位:
GFP IMAGING FOR IN VIVO HIGH-THROUGHPUT DRUG SCREENING
-
批准号:6446853
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2001
-
负责人:MENG YANG
-
依托单位:
GFP IMAGING FOR IN VIVO HIGH-THROUGHPUT DRUG SCREENING
-
批准号:6287889
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2001
-
负责人:MENG YANG
-
依托单位: